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Contribution of the Risk Factor Concept to Patient Care
in Coronary Heart Disease
FRITS L. MEDLER, MD, FAce
Utrecht. The Netherlands
This article deals with the question of whether or not
the risk factor concept, a principal aspect of preventive
cardiology, has contributed to patient care in coronary
heart disease. The risk factors considered are plasma
cholesterol, high blood pressure, smoking, diabetes and
marked obesity. With the exception of plasma choles-
terol and diabetes, all of these factors enhance myo-
cardial oxygen consumption and thus, in the presence
of coronary insufficiency, promote myocardial ischemia.
Their modification is therefore good general medical
practice, even if not related to coronary atherosclerosis.
Diabetes needs adequate medical treatment in patients
both with and without coronary atherosclerosis.
Cardiology has witnessed great stride s in the diagnosis and
therapy of congenital and acquired heart diseases during the
past 25 years . In the field of diagnosi s many new techniques
such as coronary arteriography , clinical electrophysiology ,
echocardiography and nuclear cardiology have been devel-
oped and have contributed to the diagnostic arsenal of clin-
ical cardiology. Coronary arteriography ( I) has dramatically
improved our knowledge of and changed our approach to
coronary heart disease. In the field of therapy we have seen
progre ss in surgery for congenital, valvular and coronary
heart disease and more recently for arrhythmias (2). Cor-
onary bypass surgery has had a major beneficial impact on
the life of many patients with coronary heart disease . Sim-
ilarly, the pharmacologic approach to the treatment of coro-
nary heart disease has changed significantly . A great number
of people with coronary heart disease live symptom-free
and fruitful lives, instead of being disabled or dead as a re-
sult of the introduction of beta-receptor blocking agents (3).
In the last decade our arsenal has been further extended by
a new group of drugs, the so-called calcium antagonists (4).
The recent development of percutaneous transluminal
coronary angioplasty (5) and intracoron ary streptokinase in-
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Because of the occasional occurrence of spontaneous
regression of coronary atherosclerosis and the morpho-
logic and functional complexity of coronary artery pa-
thology, it has never been and probably never will be
demonstrated that lowering plasma cholesterol levels by
diet or other means will cause regression of coronary
atherosclerosis. It follows that modification or treatment
of risk factors is implemented for good medical reasons
but does not demonstrably or predictably affect coronary
artery disease. It is concluded that the contribution of
the risk factor concept to patient care in coronary heart
disease has been, and still is, trivial.
fusion for angina pectori s and acute or impending myo-
cardial infarction, respectively (6,7) , may add new dimen-
sions to the therapy and improve the prognosis of patient s
with coronary heart disease . From its initial conception in
1958 by Chardack (8) to its present space technology form,
the electronic pacemaker has secured its place in daily car-
diologic practice. Not every technologic development is a
medical improvement, as Parsonnet (9) recently indicated
when he characterized the latest generation of pacemakers
as " a treatment in search of a disease ." But there can be
no doubt that developments in diagnosis and therapy have
had an enormous positive impact on the patient with heart
disease , especially on those with coronary heart disease .
The sums of money and intellectu al skill that so suc-
cessfull y developed new diagn ostic techniques . drugs and
types of surgical procedures for cardiovascular disease dur-
ing the past 25 years have probably been equaled by the
funds and efforts spent on the prevention of coronary heart
disease . It is true that when a disease is prevented, the person
affected does not become a patient and thus require s no
care . However, preventive cardiology has delivered a set
of rules and options for healthy persons that are also freely
propagated for and applied to patients with coronary heart
disease as if these rules had a specific sign ificance of their
own.
Because epidemiology and prevention of coronary heart
disease have consumed so much of our funding and atten-
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tion, and because modification of risk factors is being ad-
vocated as a guide to clinical decisions in coronary heart
disease (10.11). it is important to reflect on the role and
contribution of such a risk factor concept to patient care.
Definitions
Any discussion of preventive cardiology and risk factors
calls for proper definitions of terms (12). Prevention of
coronary heart disease can be divided into primary and sec-
ondary prevention. Primary prevention of coronary heart
disease is any action or measure to forestall the occurrence
of coronary artery disease (coronary atherosclerosis. for ex-
ample). Secondary prevention of coronary heart disease is
any action or set of measures taken to prevent coronary
heart disease in the presence of coronary artery disease.
Prevention is not the same as treatment of clinical signs and
symptoms in patients known to have coronary heart disease.
In practice it is difficult, if not impossible. to distinguish
between primary and secondary prevention.
Coronary artery disease versus coronary heart dis-
ease. It is essential to differentiate between these two con-
ditions. Coronary artery disease is any demonstrable func-
tional or morphologic abnormality of the coronary artery
system. Coronary heart disease is any clinical sign or symp-
tom or combination of those due to myocardial ischemia
and coronary insufficiency caused by coronary artery dis-
ease. Coronary artery disease can be present without cor-
onary heart disease (13). Thus. angina pectoris in a patient
with valvular aortic stenosis and normal coronary arteries
should not be called coronary heart disease. Coronary ath-
erosclerosis is atherosclerosis of one or more coronary ar-
teries. The diagnosis of coronary atherosclerosis can be
made only by inference from a coronary arteriogram. be-
cause the arteriogram gives no direct information about the
causes of the obstructions or narrowings observed. although
at autopsy the majority of cases prove to be due to athero-
sclerosis. As will be seen later. coronary atherosclerosis can
present itself in so many forms that the uniformity of the
underlying metabolic process is open to serious question.
Coronarv insufficiency is the pathophysiologic mecha-
nism resulting in myocardial ischemia. Coronary insuffi-
ciency occurs when the demand for coronary artery perfu-
sion surpasses the supply. This may be due to morphologic
or functional abnormalities of the coronary arteries and/or
to small vessel disease. such as that thought to be present
in the so-called syndrome X (14): coronary heart disease
without demonstrable coronary artery disease.
Thus.four different terms should be differentiated, These
are:
I. Coronary heart disease: the clinical syndrome
2. Coronary insufficiency: the underlying pathophysiologic
mechanism
3. Coronary artery disease: morphologic or functional ab-
normalities of the coronary arteries that may cause coro-
nary insufficiency
4. Coronary atherosclerosis: the polymorphic narrowing of
the coronary arteries in atherosclerosis.
In recent years it has been demonstrated that so-called cor-
onary spasm may occur in apparently normal coronary ar-
teries or arteries narrowed by atherosclerosis. or both (15,16).
Risk Factors
The pillars of preventive cardiology are the risk factors. A
striking feature of a risk factor is that hardly anyone is
concerned about its proper definition. For instance. the re-
cent report on the rationale of the diet-heart statement by
an American Heart Association committee (17) fails to de-
fine a risk factor. although the term is used in the text many
times.
When a definition ofrisk factors is given in a paper or
a report. it often differsfrom the definition in another paper.
One may find. "those factors found to be statistically as-
sociated with an increased incidence of the disease" (18),
or "characteristics which are associated with an increased
risk of developing coronary heart disease" (19). When one
takes these definitions literally. one will soon notice that
the most absurd variables such as the sale of nylon stockings
or number of television sets become risk factors. as already
suggested by Yudkin in 1957 (20). Ideally. a factor should
be called a risk factor only if. on elimination of that factor.
the incidence of coronary heart disease would decrease ( 12).
But for a critical appraisal of the contribution of risk factors
to patient care in coronary heart disease. one needs to con-
form to the broad concept as it is generally used and that
is. "a relation between certain conditions or circumstances
and the incidence of coronary heart disease ."
As it is the purpose of this paper to discuss the contri-
bution of the risk factor concept to patient care. an attempt
will be made to analyze the pathophysiologic contribution
of each factor to coronary heart disease symptomatology
and therapy. In this context. it is important to remember
the difference between primary and secondary prevention
and thus between those (risk) factors that advance coronary
arterv disease and those factors that (also) contribute to
coronary heart disease when coronary artery disease is present.
An extensive list of risk factors can be found in Black-
burn's chapter in Progress in Cardiology (2 I). The two
most prominent risk factors, the male sex and one's family
history (22), cannot be manipulated. This leaves those risk
factors whose modification according to the current rec-
ommendations of the American Heart Association should
decrease the danger of coronary heart disease (17). These
risk factors include: I) elevated plasma cholesterol, :2) el-
evated blood pressure. 3) smoking. 4) diabetes mellitus. and
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5) marked obesity. Suppose preventive cardiology had not
come forth with these five factors. Would patient care have
suffered?
Cholesterol and Coronary Artery Disease
There is scanty, if any, evidence that lowering the plasma
cholesterol level by either diet or other means has a bene-
ficial effect on the clinical status of a patient with coronary
heart disease (23). Regression of atherosclerosis in general
or of coronary atherosclerosis in particular by means of
relatively drastic "therapeutic" interventions is still very
much in doubt, but may perhaps become clinically relevant
in the future (24,25). The optimists. however. should be
aware that spontaneous regression of seemingly permanent
stenosis in coronary arteries does also occur. This is sup-
ported by studies of coronary arteriograms in patients with
coronary artery disease and coronary heart disease (Fig. I).
Figure L Coronary arteriograms of a male patient born on September 6.
1926. The 1973 film (top) shows a severe stenosis proximally in the left
anterior descending coronary artery. At that time the patient had an im-
pending myocardial infarction. His serum cholesterol was 5.5 mmol/liter.
In 1982 (bottom) there is almost complete regression of the stenosis: serum
cholesterol was 5.2 mmoilliter. Both films were obtained in the left anterior
oblique position with cranial angulation.
Regression of a lesion in one artery is often associated with
progression of narrowing in other branches (26.27). More-
over, establishing the degree or severity of coronary ath-
erosclerosis is a precarious undertaking. The endless vari-
ability of morphologic and functional abnormalities and the
unpredictability of the degree of coronary artery disease in
any given patient with symptoms of coronary heart disease
(12,25) seem to defy a rational approach to the study of
regression of coronary artery disease. Any true quantitative
analysis, and thus comparison of different degrees of cor-
onary atherosclerosis, is nearly impossible.
Wide spectrum of coronary artery abnormalities. Al-
though in general, older people seem to have disease in-
volving more vessels than do younger men and WOmen,
each clinical syndrome may be associated with a wide spec-
trum of anatomic arterial abnormalities (Table I). For in-
stance, one may find a single circumscribed stenosis in one
coronary artery while the rest of the coronary artery tree
seems to be perfectly normal. On the other hand. a seem-
ingly totally different type of coronary pathology is formed
by the so-called rosary type of abnormality in one or all of
the major branches of the coronary system (Fig. 2). These
and other forms of atherosclerotic coronary artery lesions
may occur in patients of the same sex and age with the
same symptoms and electrocardiographic abnormalities. Other
patients may have a single fixed stenosis in each of the three
major coronary arteries or may present themselves with
spasm in one or more branches. Figure 3 illustrates multiple
stenoses in all branches of the left coronary artery. The
different types of coronary arteriograms that may be found
in patients with coronary heart disease are summarized in
Table I.
In our experience, the appearance of a coronary lesion
011 all arteriogram cannot be predicted from the clinical
picture. Severe and disabling angina pectoris may be ac-
companied by a single circumscribed narrowing in one ar-
Table l. List of Anatomic and Functional Findings From
Coronary Arteriograms in Patients With Clinical Signs and
Symptoms of Coronary Heart Disease
I. Normal coronary arteries
2. Circumscribed solitary lesion in one artery
3. Circumscribed solitary lesion in two or more major branches
4. Diffusely narrowed arteries with or without local obstructions
5. "Rosary" type abnormalities in one. two or all three coronary
arteries
6. Coronary spasm with or without anatomic lesions in one or more
major branches
7. Findings 2 through 6 with coronary collateral vessels
8. Slow flow of dye in the coronary artery system
9. Aneurysmal dilations in one or more coronary arteries
10. Abnormal origin of one of the coronary arteries
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Figure 2. Coronary arteriogram of a male patient born on September 24.
1931. The patient had an 8 year history of angina pectoris (class II. New
York Heart Association) and progression of complaints for 3 months. The
film shows the right coronary artery in the right anterior oblique position.
The artery shows a so-called rosary type of abnormality with collaterals
via the septum to the left anterior descending coronary artery.
tery while mild angina with a good exercise tolerance may
be associated with multiple stenoses in all major branches.
The undeniable conclusion is that a patient with predictable
and typical abnormalities of the coronary arteries does not
exist.
Lowering Blood Pressure
Increased blood pressure is an accepted risk factor for the
development of coronary artery disease in patients with cor-
Figure 3. Coronary arteriogram of a female patient born on August 14.
J926. The patient had a 5 year history of angina pectoris (class III, New
York Heart Association). nightly attacks since 6 weeks and electrocar-
diographic findings of an inferior wall myocardial infarction. All branches
of the left coronary artery show multiple stenoses (arrows).
onary heart disease and hypertension. and reducing the blood
pressure has a beneficial effect through a decrease in myo-
cardial oxygen consumption (28,29). Treatment of elevated
blood pressure in patients with angina pectoris is beneficial
even if the hypertension was not contributing to the genesis
of coronary atherosclerosis. Control of blood pressure is
also important in the treatment of cardiogenic shock. and
efforts to reduce the infarct size in patients with myocardial
infarction with afterload reduction have become a more or
less accepted form of therapy in selected patients (30-32).
Conclusion. Lowering blood pressure in patients with
hypertension diminishes myocardial oxygen consumption.
and therefore may restore the balance between oxygen de-
mand and oxygen supply of the myocardium. Thus, low-
ering an elevated blood pressure is important in the care of
patients with coronary heart disease, independent of its po-
tential role as a risk factor for coronary atherosclerosis.
Smoking
Cigarette smoking is a major riskfactorfor coronary artery
disease, and cessation of smoking reduces the risk of cor-
onary heart disease (33). But this is not the only reason why
a cardiologist will advise his patients with coronary heart
disease to stop smoking. Cigarette smoking increases heart
rate and arterial blood pressure and has a direct effect on
myocardial oxgen consumption and coronary perfusion (34-
36). Therefore, even if cigarette smoking should prove not
to promote atherosclerosis, smoking should be discouraged
in patients with coronary heart disease because of its po-
tential for increasing the oxygen consumption of the
myocardium.
Diabetes Mellitus
Diabetes mellitus is a major precursor of atherosclerosis
and small vessel disease (37). This, however, is not nec-
essarily the main reason for proper treatment of diabetes
mellitus. Diabetes mellitus is an independent disease that
should be treated for several reasons, all of which endanger
a patient's well-being and longevity. Therefore, prevention
of atherosclerosis is not the prime reason for control of
diabetes mellitus. Although diabetes may promote athero-
sclerosis and consequently contribute to the incidence of
coronary heart disease, we should be cautious about linking
coronary heart disease to diabetes mellitus in all patients
with coronary heart disease accompanied by diabetes. Be-
cause coronary heart disease due to coronary atherosclerosis
often occurs in the absence of any carbohydrate metabolism
abnormality, the combination of the two diseases does not
necessarily reflect a cause and effect relation. This IS sup-
ported by the fact that in societies where coexistence of
coronary heart disease and diabetes is relatively rare, the
prevalence of coronary atherosclerosis is also relatively
rare (38).




Whether or not marked obesity is an independent risk factor
(17) , fundamental laws of thermodynamics dictate that all
weight. and certainly overweight carried by the body, re-
quires physical energy that has to be provided by the myo-
cardium . Moreover , exce ss weight contributes to hyperten-
sion which is an additional incenti ve for weight reducti on
(39). Thu s, whether or not obe sity is an independent risk
factor , weight reduction is an essenti al part of medical treat-
ment of patients with coron ary heart disease .
Further Considerations
Rationale for making dietary recommendations for
prevention, If we accept the notion that a relation between
certain conditions or circumstances and the incidence of
coronary heart disease is a risk factor. then the question
whether the risk factor concept is applicable or of potential
value to the individual patient with co ronary heart disease
is justifiable . Some risk factors can be avoided , such as
cigarette smoking . Others ca n be alleviated . as for exampl e.
hypertension and obe sity . There is no que stion that smoking
and , when appropriate. intake of salt should be discouraged
while antihypertensive treatm ent sometimes should be en-
couraged . The major unresolved issues are the role of plasma
cholesterol and the question: Should patients with coronary
heart disease change the ir eatin g hab its to achieve regre ssion
of co ronary atheroscleros is and lessen ing of their symp-
toms? Whether the available ev idenc e linking the lipid com-
position of diet s to the inciden ce of and death from coron ary
heart disease (40) is sufficiently convincing to allow gov-
ernments to decide what one should or should not eat is not
pertin ent to the questions raised in this paper. Evidently
much more proof is necessary to convince the population
and their governments that they should change their eating
habit s. The rationale for makin g dietary recommendations
for prevention of coronary heart disease has been questioned
by prom inent investi gators (4 1- 44) and groups ( 18). Th e
Nutr ition Committee of the American Heart Associati on has
ackn owledged the current difference of opinion on this sub-
jec t ( 17).
l ] the rationale f or prophylactic dietary changes in the
population at large is not generally convincing, what about
dietary recommendations for patients with coronary heart
disease? The latter question . however. cannot be totall y
separated from the former because the arguments in support
of dietary recommendations for pat ients are based on in-
formation obtained in epid emi ologic and ex perimental stud-
ies. Consequ entl y , one may question whether the end point s
used in those studies are valid or even transferable to clini cal
situations .
Establishing the diagnosis of coronary atherosclero-
sis, In the aforementioned Ameri can Heart Association 's
Committee report on the rationale of the diet-heart statement
(17), one may read that the fundamental goa l is to prevent
cardio vascular disease and , in part icular , to reduc e the in-
cidence of coronary heart disease and other atherosclerotic
diseases in our soc iety. Suppose that atherosclerosis is a
uniform process in the human organism and if the funda-
mental goa l is to reduce atherosclerosis by mean s of chang-
ing the (American) diet, the question can be raised as to the
exi stence of evidence that atherosclerosis is present in a
give n popul ation. For instance , if the relative prevalence of
atheroscle ros is is defined by the number of heart attac ks,
as is done in some popul ation s, one may raise the question
as to the definition of a heart attack . Is it a myocardial
infarction. sudden death, pulm onary edema or ventricular
tachy arrhythmias? One cannot assume that even the most
classic symptoms of coronary heart disease can be freely
transposed to atherosclerosis . As early as 1972. thus before
the coronary spasm "boom," Friesinger and Smith (45 )
demonstrated that, althou gh unusual , normal coronary ar-
terie s could be present on arteriogra ms in patients with an-
gina pectoris . Thi s finding impl ies that clinical symptoms
of co ronary heart disease are not necessarily related to de-
monstrable coronary atherosclerosis .
There fore , if we are to use epidemiol ogy as a guide to
clini cal decision makin g in coronary heart disease , we need
to be certain that the epid emiologic data are valid and ap-
plicable to daily cardi ologic practice.
Myocardial ischemia in absence of coronary artery
disease. Clinical symptoms of myocardi al ischemia due to
coronary artery disease can often be discovered by carefully
taking the patient ' s history , rarely by physical examination,
sometimes with the aid of an electrocardiogram obtained at
rest. during exercise or dur ing 24 hour ambulatory record-
ing, sometimes with isotope imag ing and. perhaps in not
the too distant future, with adapted digital subtraction tech-
niques, nuclear magnetic resonance, or both. If there is
evidence of local myocardial ischemia. we may assume with
confidence that coronary perfusion has been impaired .
Nevertheless. we should be careful about assuming the pres-
ence of coro nary artery disease. because subendocardial
ischemia or injury may occasionally be a result of elevated
left ventricular end-diastolic pressure (46) or small vessel
disease .
Although Stamler (47) decl ares that , "In the overwhelm-
ing majo rity of cases (90% or more) clin ical coronary heart
disease (sudden death , myocardial infarction , congestive
heart failure , unstabl e and stable angina pectoris) results
from severe atheroscleros is of coro nary arteries, often in-
volving two or more vesse ls ." James (48) warns aga inst
oversimplification. He states , "Finally. in recognizing that
sudden death and severe coro nary (artery) disease ofte n
coe xist in men of middle age or beyond. we must not lose
sight of the wealth of inform ation to be had from many
other form s of sudden death in which coronary disease plays
little or no role."
Not only sudden death. but other symptoms of coronary
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heart disease, such as myocardial infarction, can occasion-
ally appear without demonstrable coronary artery disease as
well (49). This implies that coronary heart disease, even in
the presence of severe coronary atherosclerosis, need not
always be caused by the atherosclerosis. The equalization
of coronary heart disease and coronary atherosclerosis is an
oversimplification at best and a scientific mistake at worst.
Therefore, also for purely epidemiologic purposes, the con-
cept that coronary heart disease and coronary atherosclerosis
are interchangeable is probably overstretched.
Variability of pathologic patterns. Because the pattern
of coronary artery disease is complicated and unpredictable,
the application of epidemiologic rules to the clinical situ-
ation and especially to the individual patient is even more
precarious. We learned from coronary arteriography that in
patients with a variety of signs and symptoms of coronary
heart disease, at least 10 different types of coronary ab-
normalities may be found, but their presence is unpredict-
able (Table I). Not only is it possible to divide coronary
artery disease into one, two and three vessel disease as well
as left main stem disease, but the functional and anatomic
abnormalities of each artery may differ significantly in pa-
tients with the same numbers of vessels involved and among
patients with different numbers of vessels involved in the
disease. All these different abnormalities mayor may not
be related to atherosclerosis.
It is difficult to understand that a single metabolic dis-
order can be responsible for such a variety of morphologic
changes involving one, two or all of the coronary arteries.
Moreover, there is no explanation why the lipid composition
of the diet by way of serum cholesterol would affect one
arterial system while doing no harm to the rest of the arterial
vasculature. Although from an epidemiologic viewpoint there
may be some logic in attempts to influence coronary artery
disease by lowering plasma cholesterol levels by dietary
means or with drugs, proof of a lasting and quantitatively
significant regression of coronary atherosclerosis as a result
of lowering the plasma cholesterol level in a patient with
coronary heart disease has yet to be reported. Thus, simple
rules, such as changing the diet to reduce symptoms of
coronary heart disease or attain regression of coronary ath-
erosclerosis, may not be applicable to patients with coronary
heart disease.
Despite all this skepticism. general rules and common
sense should prevail. The risk factors linked to primary
prevention also playa role in secondary prevention and are
part of a sensible therapeutic approach to patients with cor-
onary heart disease. However, the contribution of the risk
factor concept to patient care in coronary heart disease has
been trivial. The scientific basis for the application of the
risk factor concept per se to the individual patient has been
severely overstretched.
No wonder that in his article, "The Rise and Fall of
Epidemiology," Rothman (50) states that, "Among the
legacies (of epidemiology) is the demise of major 20th Cen-
tury epidemics attributable to tobacco, dietary fats, and some
carcinogens in the work place and environment. "
Conclusion
Considering the major risk factors linked with coronary heart
disease and the contribution of their identification and mod-
ification to the care of patients with coronary heart disease,
we can only conclude that their impact has been trivial. The
factors, male sex and heredity, cannot be manipulated.
Quantitative regression of coronary sclerosis by measures
that lower cholesterol level has yet to be demonstrated;
reduction of blood pressure, cessation of cigarette smoking,
treatment of diabetes mellitus and weight reduction are rea-
sonable and appropriate measures in patients with or without
coronary heart disease, even if the idea of modification of
risk factors had never entered the minds of cardiologists.
On the basis of these considerations it must be concluded
that the contribution of risk factors to the daily care of
patients with coronary heart disease is like an elephant that
has delivered a mouse.
Final Remarks
For a non-American member of the American College of
Cardiology, it is an honor and a pleasure to contribute to
this anniversary issue of the College's journal. As far as I
may represent cardiology in The Netherlands, we wish the
Journal of the American College of Cardiology every suc-
cess on its way to spreading cardiologic knowledge and
expertise among cardiologists all over the world. I thank
the guest editor of this issue for giving me the opportunity
to make this contribution.
I thank my close associates. Etienne O. Robles de Medina, MD. FACC.
Tjeerd van der Werf, MD and Pieter W. Westerhof. MD for their support
and critical comments.
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